Clinical efficacy and drug resistance of ceftazidime-avibactam in the treatment of Carbapenem-resistant gram-negative bacilli infection
ObjectiveTo examine the clinical efficacy, safety, and resistance of Ceftazidime-Avibactam (CAZ-AVI) in patients with Carbapenem-resistant Gram-negative bacilli (CR-GNB) infections.MethodsWe retrospectively analyzed relevant data of CR-GNB infected patients receiving CAZ-AVI treatment, analyzed rele...
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
Frontiers Media S.A.
2023-08-01
|
| Collection: | Frontiers in Microbiology |
| Sujets: | |
| Accès en ligne: | https://www.frontiersin.org/articles/10.3389/fmicb.2023.1198926/full |